Tandem Investment Advisors Inc. Reduces Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tandem Investment Advisors Inc. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.2% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,738 shares of the medical equipment provider's stock after selling 1,216 shares during the period. Tandem Investment Advisors Inc.'s holdings in Intuitive Surgical were worth $4,328,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. AlphaCore Capital LLC grew its holdings in Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after purchasing an additional 18 shares during the last quarter. Accredited Investors Inc. boosted its position in shares of Intuitive Surgical by 1.9% during the fourth quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock valued at $543,000 after buying an additional 19 shares during the period. Second Line Capital LLC grew its stake in shares of Intuitive Surgical by 3.4% during the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after buying an additional 19 shares during the last quarter. Colonial Trust Co SC raised its holdings in shares of Intuitive Surgical by 8.8% in the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock worth $128,000 after buying an additional 20 shares during the period. Finally, Crown Wealth Group LLC raised its holdings in shares of Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after buying an additional 20 shares during the period. Institutional investors own 83.64% of the company's stock.

Insider Activity

In other news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president directly owned 5,224 shares of the company's stock, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president directly owned 2,245 shares of the company's stock, valued at $1,152,089.10. The trade was a 43.09% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. Insiders own 0.70% of the company's stock.

Analyst Ratings Changes

A number of research firms recently issued reports on ISRG. Piper Sandler dropped their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Citigroup reissued a "buy" rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Robert W. Baird cut their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Royal Bank Of Canada reduced their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

Intuitive Surgical Trading Up 0.6%

Shares of NASDAQ:ISRG traded up $3.14 on Thursday, reaching $543.74. The company had a trading volume of 704,815 shares, compared to its average volume of 1,670,474. The firm has a market capitalization of $194.89 billion, a PE ratio of 79.73, a PEG ratio of 5.73 and a beta of 1.64. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The firm's 50 day simple moving average is $535.82 and its 200-day simple moving average is $536.76.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the previous year, the firm earned $1.50 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.